Cardiopulmonary Exercise Testing in Heart Failure

Current Problems in Cardiology

Volumn 40, Issue 8, 2015, Pages 322-372

  Myers, Jonathan ^a   Arena, Ross ^a   Cahalin, Lawarence P ^a   Labate, Valentina ^a   Guazzi, Marco ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE;

ARTICLE; BREATHING MUSCLE; CARBON DIOXIDE TENSION; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR PARAMETERS; CLINICAL EVALUATION; CONCEPTUAL FRAMEWORK; DISEASE SEVERITY; EXERCISE OSCILLATORY VENTILATION; EXERCISE TOLERANCE; EXERCISE VENTILATORY POWER; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART MUSCLE OXYGEN CONSUMPTION; HEART RIGHT VENTRICLE FUNCTION; HUMAN; LUNG CIRCULATION; LUNG DIFFUSION CAPACITY; LUNG GAS EXCHANGE; LUNG MINUTE VOLUME; LUNG VENTILATION; MUSCLE FUNCTION; MUSCLE TRAINING; OXYGEN PULSE; OXYGEN UPTAKE EFFICIENCY SLOPE; PATIENT IDENTIFICATION; PHYSICAL CAPACITY; PULMONARY HYPERTENSION; RESPIRATORY MUSCLE PERFORMANCE; RESPIRATORY TRACT PARAMETERS; RISK ASSESSMENT; VENTILATORY THRESHOLD; DISABILITY; EXERCISE TEST; KINESIOTHERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS;

DISABILITY EVALUATION; EXERCISE TEST; EXERCISE THERAPY; EXERCISE TOLERANCE; HEART FAILURE; HUMANS; PROGNOSIS;

EID: 84937544903     PISSN: 01462806     EISSN: 15356280     Source Type: Journal    
DOI: 10.1016/j.cpcardiol.2015.01.009     Document Type: Article

References (158)

1. Bui A.L., Horwich T.B., Fonarow G.C. Epidemiology and risk profile of heart failure. Nat Rev Cardiol 2011, 8:30-41.
2. Roger V.L. Epidemiology of heart failure. Circ Res 2013, 113:646-659.
3. Weiner D.A., Ryan T.J., McCabe C.H., et al. Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease. J Am Coll Cardiol 1984, 3:772-779.
4. Morris C.K., Ueshima K., Kawaguchi T., Hideg A., Froelicher V.F. The prognostic value of exercise capacity: a review of the literature. Am Heart J 1991, 122:1423-1431.
5. Chang J., Froeloicher V.F. Clinical and exercise test markers of prognosis in patients with stable coronary artery disease. Curr Probl Cardiol 1994, 19:539-587.
6. Sullivan M., Genter F.F., Savvides M., Roberts M., Myers J., Froelicher V. The reproducibility of hemodynamic, electrocardiographic, and gas exchange data during treadmill exercise in patients with stable angina pectoris. Chest 1984, 86:375-382.
7. Haskell W., Savin W., Oldridge N., DeBusk R. Factors influencing estimated oxygen uptake during exercise testing soon after myocardial infarction. Am J Cardiol 1982, 50:299-304.
8. Sullivan M., McKirnan M.D. Errors in predicting functional capacity for postmyocardial infarction patients using a modified Bruce protocol. Am Heart J 1984, 107:486-491.
9. Starling M.R., Moody M., Crawford M.H., Levi B., O'Rourke R.A. Repeat treadmill exercise testing: variability of results in patients with angina pectoris. Am Heart J 1984, 107:298-303.
10. Elborn J.S., Stanford C.F., Nichols D.P. Reproducibility of cardiopulmonary parameters during exercise in patients with chronic cardiac failure: the need for a preliminary test. Eur Heart J 1990, 11:75-81.
11. Pinsky D.J., Ahern D., Wilson P.B., Kukin M.L., Packer M. How many exercise tests are needed to minimize the placebo effect of serial exercise testing in patients with chronic heart failure?. Circulation 1989, 80:426.
12. Myers J., Froelicher V.F. Optimizing the exercise test for pharmacologic investigations. Circulation 1990, 82:1839-1846.
13. Mancini D.M., Eisen H., Kussmaul W., Mull R., Edmunds L.H., Wilson J.R. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991, 83:778-786.
14. Stelken A.M., Younis L.T., Jennison S.H., et al. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J Am Coll Cardiol 1996, 27:345-352.
15. Myers J., Gullestad L., Vagelos R., et al. Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure. Ann Intern Med 1998, 129:286-293.
16. Myers J., Gullestad L. The role of exercise testing and gas-exchange measurement in the prognostic assessment of patients with heart failure. Curr Opin Cardiol 1998, 13:145-155.
17. Arena R., Myers J., Guazzi M. The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure: an evidence-based review. Heart Fail Rev 2008, 13:245-269.
18. Myers J., Gullestad L., Vagelos R., et al. Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited. Am Heart J 2000, 139:78-84.
19. Roul G., Moulichon M.E., Bareiss P., et al. Exercise peak VO2 determination in chronic heart failure: is it still of value?. Eur Heart J 1994, 15:495-502.
20. Balady G.J., Arena R., Sietsema K., et al. Clinician's guide to cardiopulmonary exercise testing in adults. a scientific statement from the american heart association. Circulation 2010, 122:191-225.
21. Piepoli M.F., Corra U., Agostoni P.G., et al. Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation Part III: interpretation of cardiopulmonary exercise testing in chronic heart failure and future applications. Eur J Cardiovasc Prev Rehabil 2006, 13:485-494.
22. American Thoracic Society/American College of Chest Physicians ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003, 167:211-277.
23. Guazzi M., Adams V., Conraads V., et al. EACPR/AHA scientific statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation 2012, 126:2261-2274.
24. 2 slope in chronic heart failure. Eur J Cardiovasc Prev Rehabil 2003, 10:267-272.
25. Arena R., Myers J., Aslam S., Varughese E.B., Peberdy M.A. Technical considerations related to the minute ventialtion/carbon dioxide output slope in patients with heart failure. Chest 2003, 124:720-727.
26. Arena R., Myers J., Abella J., et al. Development of a ventilatory classification system in patients with heart failure. Circulation 2007, 115:2410-2417.
27. Guazzi M. Abnormalities in cardiopulmonary exercise testing ventilatory parameters in heart failure: pathophysiology and clinical usefulness. Curr Heart Fail Rep 2014, 11:80-87.
28. Guazzi M., Cahalin L.P., Arena R. Cardiopulmonary exercise testing as a diagnostic tool for the detection of left-sided pulmonary hypertension in heart failure. J Card Fail 2013, 19:461-467.
29. Lim H.S., Theodosiou M. Exercise ventilatory parameters for the diagnosis of reactive pulmonary hypertension in patients with heart failure. J Card Fail 2014, 20:650-657.
30. Lewis G.D., Shah R.V., Pappagianopolas P.P., Systrom D.M., Semigran M.J. Determinants of ventilatory efficiency in heart failure: the role of right ventricular performance and pulmonary vascular tone. Circ Heart Fail 2008, 1:227-233.
31. 2 slope) associated with right ventricular oxidative metabolism in patients with congestive heart failure?. Eur J Heart Fail 2008, 10:1117-1122.
32. Damy T., Goode K.M., Kallvikbacka-Bennett A., et al. Determinants and prognostic value of pulmonary arterial pressure in patients with chronic heart failure. Eur Heart J 2010, 31:2280-2290.
33. Ghio S., Gavazzi A., Campana C., et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 2001, 37:183-188.
34. Kalogeropoulos A.P., Vega J.D., Smith A.L., Georgiopoulou V.V. Pulmonary hypertension and right ventricular function in advanced heart failure. Congest Heart Fail 2011, 17:189-198.
35. Ingle L. Prognostic value and diagnostic potential of cardiopulmonary exercise testing in patients with chronic heart failure. Eur J Heart Fail 2008, 10:112-118.
36. Ingle L., Rigby A.S., Sloan R., et al. Development of a composite model derived from cardiopulmonary exercise tests to predict mortality risk in patients with mild-to-moderate heart failure. Heart 2014, 100:781-786.
37. Corra U., Mezzani A., Bosimini E., Scapellato F., Imparato A., Giannuzzi P. Ventilatory response to exercise improves risk stratification in patients with chronic heart failure and intermediate functional capacity. Am Heart J 2002, 143:418-426.
38. Francis D.P., Shamim W., Davies L.C., et al. Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2). Eur Heart J 2000, 21:154-161.
39. Guazzi M., Arena R. The impact of pharmacotherapy on the cardiopulmonary exercise test response in patients with heart failure: a mini review. Curr Vasc Pharmacol 2009, 7:557-569.
40. Guazzi M., Myers J., Peberdy M.A., Bensimhon D., Chase P., Arena R. Ventilatory efficiency and dyspnea on exertion improvements are related to reduced pulmonary pressure in heart failure patients receiving Sildenafil. Int J Cardiol 2010, 144:410-412.
41. Guazzi M., Vicenzi M., Arena R., Guazzi M.D. PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure/clinical perspective. Circ Heart Fail 2011, 4:8-17.
42. Van Tassell B.W., Arena R.A., Toldo S., et al. Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure. PLoS ONE 2012, 7:e33438.
43. Myers J., Dziekan G., Goebbels U., Dubach P. Influence of high-intensity exercise training on the ventilatory response to exercise in patients with reduced ventricular function. Med Sci Sports Exerc 1999, 31:929-937.
44. Kim C.H., Cha Y.M., Shen W.K., MacCarter D.J., Taylor B.J., Johnson B.D. Effects of atrioventricular and interventricular delays on gas exchange during exercise in patients with heart failure. J Heart Lung Transplant 2014, 33:397-403.
45. 2 abnormality and exercise limitation in patients with primary pulmonary hypertension. Chest 2005, 127:1637-1646.
46. 2 pressure and cardiac performance during exercise in heart failure. Med Sci Sports Exerc 2009, 41:19-25.
47. 2 pressure decreases during exercise in cardiac patients: association with severity of heart failure and cardiac output reserve. J Am Coll Cardiol 2000, 36:242-249.
48. Arena R., Sietsema K.E. Cardiopulmonary exercise testing in the clinical evaluation of patients with heart and lung disease. Circulation 2011, 123:668-680.
49. Arena R., Guazzi M., Myers J. Prognostic value of end-tidal carbon dioxide during exercise testing in heart failure. Int J Cardiol 2007, 117:103-108.
50. Arena R., Myers J., Abella J., et al. The partial pressure of resting end-tidal carbon dioxide predicts major cardiac events in patients with systolic heart failure. Am Heart J 2008, 156:982-988.
51. Myers J., Arena R., Dewey F., et al. A cardiopulmonary exercise testing score for predicting outcomes in patients with heart failure. Am Heart J 2008, 156:1177-1183.
52. Myers J., Oliveira R., Dewey F., et al. Validation of a cardiopulmonary exercise test score in heart failure. Circ Heart Fail 2013, 6:211-218.
53. Corra U., Giordano A., Bosimini E., et al. Oscillatory ventilation during exercise in patients with chronic heart failure: clinical correlates and prognostic implications. Chest 2002, 121:1572-1580.
54. Murphy R.M., Shah R.V., Malhotra R., et al. Exercise oscillatory ventilation in systolic heart failure: an indicator of impaired hemodynamic response to exercise. Circulation 2011, 124:1442-1451.
55. Olson L.J., Arruda-Olson A.M., Somers V.K., Scott C.G., Johnson B.D. Exercise oscillatory ventilation: instability of breathing control associated with advanced heart failure. Chest 2008, 133:474-481.
56. Guazzi M., Arena R., Ascione A., Piepoli M., Guazzi M.D. Exercise oscillatory breathing and increased ventilation to carbon dioxide production slope in heart failure: an unfavorable combination with high prognostic value. Am Heart J 2007, 153:859-867.
57. Guazzi M., Myers J., Peberdy M.A., Bensimhon D., Chase P., Arena R. Exercise oscillatory breathing in diastolic heart failure: prevalence and prognostic insights. Eur Heart J 2008, 29:2751-2759.
58. Leite J.J., Mansur A.J., de Freitas H.F., et al. Periodic breathing during incremental exercise predicts mortality in patients with chronic heart failure evaluated for cardiac transplantation. J Am Coll Cardiol 2003, 41:2175-2181.
59. Guazzi M., Raimondo R., Vicenzi M., et al. Exercise oscillatory ventilation may predict sudden cardiac death in heart failure patients. J Am Coll Cardiol 2007, 50:299-308.
60. Guazzi M., Vicenzi M., Arena R. Phosphodiesterase 5 inhibition with sildenafil reverses exercise oscillatory breathing in chronic heart failure: a long-term cardiopulmonary exercise testing placebo-controlled study. Eur J Heart Fail 2012, 14:82-90.
61. Zurek M., Corrà U., Piepoli M.F., Binder R.K., Saner H., Schmid J.P. Exercise training reverses exertional oscillatory ventilation in heart failure patients. Eur Respir J 2012, 40:1238-1244.
62. Baba R., Nagashima M., Goto M., et al. Oxygen intake efficiency slope: a new index of cardiorespiratory functional reserve derived from the relationship between oxygen consumption and minute ventilation during incremental exercise. Nagoya J Med Sci 1996, 59:55-62.
63. Van L.C., Bartunek J., Goethals M., Nellens P., Andries E., Vanderheyden M. Oxygen uptake efficiency slope, a new submaximal parameter in evaluating exercise capacity in chronic heart failure patients. Am Heart J 2005, 149:175-180.
64. Sun X.G., Hansen J., Stringer W. Oxygen uptake efficiency plateau: physiology and reference values. Eur J Appl Physiol 2012, 112:919-928.
65. Ehrman J.K., Brawner C.A., Weaver D., Jacobsen G., Keteyian S.J. Oxygen uptake efficiency slope and survival in patients with systolic heart failure. J Am Coll Cardiol 2006, 47:155A.
66. Davies L.C., Wensel R., Georgiadou P., et al. Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope. Eur Heart J 2006, 27:684-690.
67. Arena R., Myers J., Hsu L., et al. The minute ventilation/carbon dioxide production slope is prognostically superior to the oxygen uptake efficiency slope. J Card Fail 2007, 13:462-469.
68. Myers J., Gademan M., Brunner K., Kottman W., Boesch C., Dubach P. Effects of high-intensity training on indices of ventilatory efficiency in chronic heart failure. J Cardiopulm Rehabil Prev 2012, 32:9-16.
69. Van Laethem C., Van De Veire N., Backer G.D., et al. Response of the oxygen uptake efficiency slope to exercise training in patients with chronic heart failure. Eur J Heart Fail 2007, 9:625-629.
70. Gademan M.G.J., Swenne C.A., Verwey H.F., et al. Exercise training increases oxygen efficiency slope in chronic heart failure. Eur J Cardiovasc Prev Rehabil 2008, 15:140-144.
71. Kemps H.M.C., de Vries W.R., Schmikli S.L., et al. Assessment of the effects of physical training in patients with chronic heart failure: the utility of effort-independent exercise variables. Eur J Appl Physiol 2001, 108:469-476.
72. Van Laethem C., Goethals M., Verstreken S., et al. Response of the oxygen uptake efficiency slope to orthotopic heart transplantation: lack of correlation with changes in central hemodynamic parameters and resting lung function. J Heart Lung Transplant 2007, 26:921-926.
73. Ashley E., Myers J., Froelicher V.F. Exercise testing scores as an example of better decisions through science. Med Sci Sports Exerc 2002, 34:1391-1398.
74. Swets J.A., Dawes R.M., Monahan J. Better decisions through science. Sci Am 2000, 283:82-87.
75. Koopman R.J., Mainous A.G. Evaluating multivariate risk scores for clinical decision making. Fam Med 2008, 40:412-416.
76. Borghi-Silva A., Labate V., Arena R., et al. Exercise ventilatory power in heart failure patients: Functional phenotypes definition by combining cardiopulmonary exercise testing with stress echocardiography. Int J Cardiol 2014, 176:1348-1349.
77. Aaronson K.D., Schwartz S.J., Chen T.M., Wong K.L., Goin J.E., Mancini D.M. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997, 95:2660-2667.
78. Lund L.H., Aaronson K.D., Mancini D.M. Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in advanced heart failure. Am J Cardiol 2005, 95:734-741.
79. Zugck C., Krüger C., Kell R., et al. Risk stratification in middle-aged patients with congestive heart failure: prospective comparison of the Heart Failure Survival Score (HFSS) and a simplified two-variable model. Eur J Heart Fail 2001, 3:577-585.
80. Guazzi M., Boracchi P., Arena R., et al. Development of a cardiopulmonary exercise prognostic score for optimizing risk stratification in heart failure: the (P)e(R)i(O)dic (B)reathing during (E)xercise (PROBE) study. J Card Fail 2010, 16:799-805.
81. Agostoni P., Corrà U., Cattadori G., et al. Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis. Int J Cardiol 2013, 167:2710-2718.
82. Forman D.E., Guazzi M., Myers J., et al. Ventilatory power: a novel index that enhances prognostic assessment of patients with heart failure. Circ Heart Fail 2012, 5:621-626.
83. 2/δWork Rate flattening: insights from cardiopulmonary exercise test combined with exercise echocardiography. Circ Heart Fail 2014, 7:782-790.
84. Myers J., Ashley E. Dangerous curves: a perspective on exercise, lactate, and the anaerobic threshold. Chest 1997, 111:787-795.
85. Myers J. Principles of exercise prescription for patients with chronic heart failure. Heart Fail Rev 2008, 13:61-68.
86. Cahalin L.P., Arena R., Guazzi M., et al. Inspiratory muscle training in heart disease and heart failure: a review of the literature with a focus on method of training and outcomes. Expert Rev Cardiovasc Ther 2013, 11:161-177.
87. Oliveira R., Myers J., Araujo C.G., Mandic S., Froelicher V. Maximal exercise oxygen pulse as a predictor of mortality among male veterans referred for exercise testing. Eur J Cardiovasc Prev Rehabil 2009, 16:359-364.
88. Wasserman K., Zhang Y.Y., Gitt A., et al. Lung function and exercise gas exchange in chronic heart failure. Circulation 1997, 96:2221-2227.
89. Light R.W., George R.B. Serial pulmonary function in patients with acute heart failure. Arch Intern Med 1983, 143:429-433.
90. Agostoni P., Marenzi G., Lauri G., et al. Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result. Am J Med 1994, 96:191-199.
91. Agostoni P., Cattadori G., Guazzi M., Palermo P., Bussotti M., Marenzi G. Cardiomegaly as a possible cause of lung dysfunction in patients with heart failure. Am Heart J 2000, 140:e24.
92. Olson T.P., Johnson B.D. Influence of cardiomegaly on disordered breathing during exercise in chronic heart failure. Eur J Heart Fail 2011, 13:311-318.
93. Cabanes L.R., Weber S.N., Matran R., et al. Bronchial hyperresponsiveness to methacholine in patients with impaired left ventricular function. N Engl J Med 1989, 320:1317-1322.
94. Roughton F.J., Forster R.E. Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in the human lung, with special reference to true diffusing capacity of pulmonary membrane and volume of blood in the lung capillaries. J Appl Physiol 1957, 11:290-302.
95. Puri S., Backer L., Dukta D.P., Oakley C., Hughes J.M.B., Cleland J.G.F. Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure. Its pathophysiological relevance and relationship to exercise performance. Circulation 1995, 91:2769e74.
96. Guazzi M. Alveolar gas diffusion abnormalities in heart failure. J Card Fail 2008, 14:695-702.
97. Guazzi M., Pontone G., Brambilla R., Agostoni P., Rèina G. Alveolar-capillary membrane gas conductance: a novel prognostic indicator in chronic heart failure. Eur Heart J 2002, 23:467-476.
98. Tsukimoto K., Mathieu-Costello O., Prediletto R., Elliott A.R., West J.B. Ultrastructural appearances of pulmonary capillaries at high transmural pressures. J Appl Physiol 1991, 71:573-582.
99. Saldías F.J., Azzam Z.S., Ridge K.M., et al. Alveolar fluid reabsorption is impaired by increased left atrial pressures in rats. Am J Physiol Lung Cell Mol Physiol 2001, 281:L591-L597.
100. Townsley M.I., Fu Z., Mathieu-Costello O., West J.B. Pulmonary microvascular permeability. Responses to high vascular pressure after induction of pacing-induced heart failure in dogs. Circ Res 1995, 77:317-325.
101. Negrini D., Passi A., de Luca G., Miserocchi G. Pulmonary interstitial pressure and proteoglycans during development of pulmonary edema. Am J Physiol 1996, 270:H2000-H2007.
102. Guazzi M., Philips S., Arena R., Lavie C. Endothelial dysfunction and lung capillary injury in cardiovascular diseases. Prog Cardiovasc Dis 2014, 10.1016/j.pcad.2014.11.003.
103. Guazzi M., Reina G., Tumminello G., Guazzi M.D. Alveolar-capillary membrane conductance is the best pulmonary function correlate of exercise ventilation efficiency in heart failure patients. Eur J Heart Fail 2005, 7:1017-1022.
104. Andrea R., López-Giraldo A., Falces C., et al. Lung function abnormalities are highly frequent in patients with heart failure and preserved ejection fraction. Heart Lung Circ 2014, 23:273-279.
105. Andersson C., Vasan R.S. Epidemiology of heart failure with preserved ejection fraction. Heart Fail Clin 2014, 10:377-388.
106. Dhingra A, Garg A, Kaur S, et al. Epidemiology of heart failure with preserved ejection fraction. Curr Heart Fail Rep. 2014.
107. Owan T.E., Hodge D.O., Herges R.M., Jacobsen S.J., Roger V.L., Redfield M.M. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006, 355:251-259.
108. Kitzman D.W., Upadhya B. Heart failure with preserved ejection fraction: a heterogenous disorder with multifactorial pathophysiology. J Am Coll Cardiol 2014, 63:457-459.
109. Ather S., Chan W., Bozkurt B., et al. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol 2012, 59:998-1005.
110. Haykowsky M.J., Kitzman D.W. Exercise physiology in heart failure and preserved ejection fraction. Heart Fail Clin 2014, 10:445-452.
111. Kitzman D.W., Higginbotham M.B., Cobb F.R., Sheikh K.H., Sullivan M.J. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol 1991, 17:1065-1072.
112. Borlaug B.A., Olson T.P., Lam C.S., et al. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol 2010, 56:845-854.
113. Bhella P.S., Prasad A., Heinicke K., et al. Abnormal haemodynamic response to exercise in heart failure with preserved ejection fraction. Eur J Heart Fail 2011, 13:1296-1304.
114. Guazzi M., Myers J., Peberdy M.A., Bensimhon D., Chase P., Arena R. Cardiopulmonary exercise testing variables reflect the degree of diastolic dysfunction in patients with heart failure-normal ejection fraction. J Cardiopulm Rehabil Prev 2010, 30:165-172.
115. Guazzi M., Labate V., Cahalin L.P., Arena R. Cardiopulmonary exercise testing reflects similar pathophysiology and disease severity in heart failure patients with reduced and preserved ejection fraction. Eur J Prev Cardiol 2013, 21:847-854.
116. Farr M.J., Lang C.C., Lamanca J.J., et al. Cardiopulmonary exercise variables in diastolic versus systolic heart failure. Am J Cardiol 2008, 102:203-206.
117. Kitzman D.W., Little W.C., Brubaker P.H., et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. J Am Med Assoc 2002, 288:2144-2150.
118. 2 slope in older heart failure patients with normal versus reduced ejection fraction compared with age-matched healthy controls. J Card Fail 2007, 13:259-262.
119. Arruda A.L., Pellikka P.A., Olson T.P., Johnson B.D. Exercise capacity, breathing pattern, and gas exchange during exercise for patients with isolated diastolic dysfunction. J Am Soc Echocardiogr 2007, 20:838-846.
120. Guazzi M., Myers J., Arena R. Cardiopulmonary exercise testing in the clinical and prognostic assessment of diastolic heart failure. J Am Coll Cardiol 2005, 46:1883-1890.
121. Witte K.K., Nikitin N.P., Cleland J.G., Clark A.L. Excessive breathlessness in patients with diastolic heart failure. Heart 2006, 92:1425-1429.
122. Palange P., Ward S.A., Carlsen K.H., et al. Recommendations on the use of exercise testing in clinical practice. Eur Respir J 2007, 29:185-209.
123. Cahalin L.P., Arena R. Breathing exercises and inspiratory muscle training in heart failure. Heart Fail Clin 2015, 11:149-172.
124. Phillips S.A., Vuckovic K., Cahalin L.P., Baynard T. Defining the system: contributors to exercise limitations in heart failure. Heart Fail Clin 2015, 11:1-16.
125. Hammond M.D., Bauer K.A., Sharp J.T., Rocha R.D. Respiratory muscle strength in congestive heart failure. Chest 1990, 98:1091-1094.
126. McParland C., Krishnan B., Wang Y., Gallagher C.G. Inspiratory muscle weakness and dyspnea in congestive heart failure. Am Rev Respir Dis 1992, 146:467.
127. Walsh J.T., Andrews R., Johnson P., Phillips L., Cowley A.J., Kinnear W.J. Inspiratory muscle endurance in patients with chronic heart failure. Heart 1996, 76:332-336.
128. Mancini D.M., Henson D., LaManca J., Levine S. Evidence of reduced respiratory muscle endurance in patients with heart failure. J Am Coll Cardiol 1994, 24:972-981.
129. Meyer F.J., Zugck C., Haass M., et al. Inefficient ventilation and reduced respiratory muscle capacity in congestive heart failure. Basic Res Cardiol 2000, 95:333-342.
130. Meyer F.J., Borst M.M., Zugck C., et al. Respiratory muscle dysfunction in congestive heart failure-clinical correlation and prognostic significance. Circulation 2001, 103:2153-2158.
131. van der Palen J., Rea T.D., Manolio T.A., et al. Respiratory muscle strength and the risk of incident cardiovascular events. Thorax 2004, 59:1063-1067.
132. Neves L.M., Karsten M., Neves V.R., Beltrame T., Borghi-Silva A., Catai A.M. Relationship between inspiratory muscle capacity and peak exercise tolerance in patients post-myocardial infarction. Heart Lung 2012, 41:137-145.
133. Daganou M., Dimopoulou I., Alivizatos P.A., Tzelepis G.E. Pulmonary function and respiratory muscle strength in chronic heart failure: comparison between ischaemic and idiopathic dilated cardiomyopathy. Heart 1999, 81:618-620.
134. Lindsay D.C., Loverove C.A., Dunn M.J., et al. Histological abnormalities of muscle from limb, thorax and diaphragm on chronic heart failure. Eur Heart J 1996, 17:1239-1250.
135. Lavietes M.H., Gerula C.M., Fless K.G., Cherniack N.S., Arora R.R. Inspiratory muscle weakness in diastolic dysfunction. Chest 2004, 126:838-844.
136. Filusch A., Ewert R., Altessellmeier M., et al. Respiratory muscle dysfunction in congestive heart failure-The role of pulmonary hypertension. Int J Cardiol 2011, 150:182-185.
137. Richter M.J., Tiede H., Morty R.E., et al. The prognostic significance of inspiratory capacity in pulmonary arterial hypertension. Respiration 2014, 88:24-30.
138. Coats A.J., Clark A.L., Piepoli M., Volterrani M., Poole-Wilson P.A. Symptoms and quality of life in heart failure: the muscle hypothesis. Br Heart J 1994, 72:S36-S39.
139. Coats A.J. The "muscle hypothesis" of chronic heart failure. J Mol Cell Cardiol 1996, 28:2255-2262.
140. Chiappa G.R., Roseguini B.T., Vieira P.J., et al. Inspiratory muscle training improves blood flow to resting and exercising limbs in patients with chronic heart failure. J Am Coll Cardiol 2008, 51:1663-1671.
141. Cahalin L.P., Forman D.E., Manning K., Allsup K. Inspiratory muscle testing and training in a patient with heart failure preserved ejection fraction and acute cardiovascular decompensation. Am J Respir Crit Care Med 2014, 189:A6453.
142. Tikunov B., Levine S., Mancini D. Chronic congestive heart failure elicits adaptations of endurance exercise in diaphragmatic muscle. Circulation 1997, 95:910-916.
143. Black L.F., Hyatt R.E. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 1969, 99:696-702.
144. Mador M.J., Magalang U.J., Rodis A., Kufel T.J. Diaphragmatic fatigue after exercise in healthy human subjects. Am Rev Respir Dis 1993, 148:1571-1575.
145. Babcock M.A., Pegelow D.F., McClaran S.R., Suman O.E., Dempsey J.A. Contribution of diaphragmatic power output to exercise-induced diaphragm fatigue. J Appl Physiol 1995, 78:1710-1719.
146. Johnson B.D., Babcock M.A., Suman O.E., Dempsey J.A. Exercise-induced diaphragmatic fatigue in healthy humans. J Physiol 1993, 460:385-405.
147. Hill N.S., Jacoby C., Farber H.W. Effect of an endurance triathlon on pulmonary function. Med Sci Sports Exerc 1991, 23:1260-1264.
148. Chevrolet J.-C., Tschopp J.-M., Blanc Y., Rochat T., Junod A.F. Alterations in inspiratory and leg muscle force and recovery pattern after a marathon. Med Sci Sports Exerc 1993, 25:501-507.
149. McConnell A.K., Caine M.P., Sharpe G.R. Inspiratory muscle fatigue following running to volitional fatigue: the influence of baseline strength. Int J Sports Med 1997, 18:169-173.
150. Warren G.L., Cureton K.J., Sparling P.B. Does lung function limit performance in a 24-hour ultramarathon?. Respir Physiol 1989, 78:253-264.
151. Loke J., Mahler D.A., Virgulto J.A. Respiratory muscle fatigue after marathon running. J Appl Physiol 1982, 52:821-824.
152. Ker J.A., Schultz C.M. Respiratory muscle fatigue after an ultra-marathon measured as inspiratory task failure. Int J Sports Med 1996, 17:493-496.
153. Perret C., Pfeiffer R., Boutellier U., Wey H.M., Spengler C.M. Noninvasive measurement of respiratory muscle performance after exhaustive endurance exercise. Eur Respir J 1999, 14:264-269.
154. Refai M., Pompili C., Salati M., Xiumè F., Sabbatini A., Brunelli A. Can maximal inspiratory and expiratory pressures during exercise predict complications in patients submitted to major lung resections? A prospective cohort study. Eur J Cardiothorac Surg 2014, 45:665-669.
155. Nanas S., Nanas J., Kassiotis C., et al. Respiratory muscles performance is related to oxygen kinetics during maximal exercise and early recovery in patients with congestive heart failure. Circulation 1999, 100:503-508.
156. Gibbons R.J., Balady G.J., Timothy B.J., et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to update the 1997 exercise testing guidelines). J Am Coll Cardiol 2002, 40:1531-1540.
157. European Association of Cardiovascular Prevention and Rehabilitation.Committee for Science Guidelines; EACPR, Corrà U., Piepoli M.F., Carré F., et al. Secondary prevention through cardiac rehabilitation: physical activity counselling and exercise training: key components of the position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur Heart J 2010, 16:1967-1974.
158. Myers J. Physical activity: the missing prescription. Eur J Cardiovasc Prev Rehabil 2005, 12:85-86.